{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:48:58Z","timestamp":1770972538867,"version":"3.50.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ijsu.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T16:02:56Z","timestamp":1596038576000},"page":"235-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Restricted access to innovative surgical technique related to a specific training, is it ethical? Example of the PIPAC procedure. A systematic review and an experts survey"],"prefix":"10.1097","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7647-4884","authenticated-orcid":false,"given":"S.","family":"Martellotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2973-0205","authenticated-orcid":false,"given":"C.","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-7821","authenticated-orcid":false,"given":"L.","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-4929","authenticated-orcid":false,"given":"C.","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-3697","authenticated-orcid":false,"given":"O.","family":"Sgarbura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-0008","authenticated-orcid":false,"given":"M.","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2020.07.004_bib1","first-page":"3","article-title":"Evidence based medicine: what it is and what it isn't","volume":"455","author":"Sackett","year":"1996","journal-title":"Clin. Orthop."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.amjmed.2015.08.001","article-title":"Reflections on the physicians payment sunshine Act","volume":"129","author":"Frishman","year":"2016","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.ijsu.2020.07.004_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0098858817753403","article-title":"Deciphering the sunshine Act: transparency regulation and financial conflicts in health care","volume":"43","author":"Saver","year":"2017","journal-title":"Am. J. Law Med."},{"issue":"9231","key":"10.1016\/j.ijsu.2020.07.004_bib4","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(00)02632-5","article-title":"Persistent pain and faecal urgency after stapled haemorrhoidectomy","volume":"356","author":"Cheetham","year":"2000","journal-title":"Lancet Lond. Engl."},{"issue":"9248","key":"10.1016\/j.ijsu.2020.07.004_bib5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/S0140-6736(05)67263-7","article-title":"Pain after stapled haemorrhoidectomy","volume":"356","author":"Longo","year":"2000","journal-title":"Lancet Lond. Engl."},{"issue":"7","key":"10.1016\/j.ijsu.2020.07.004_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ijsu.2020.07.004_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","article-title":"Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration","volume":"7","author":"Jacquet","year":"1996","journal-title":"Anti Canc. Drugs"},{"issue":"2","key":"10.1016\/j.ijsu.2020.07.004_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann. Surg Oncol."},{"issue":"12","key":"10.1016\/j.ijsu.2020.07.004_bib9","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","article-title":"How to perform safe and technically optimized pressurized intraperitoneal aerosol chemotherapy (PIPAC): experience after a consecutive series of 1200 procedures","volume":"22","author":"Giger-Pabst","year":"2018","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract."},{"issue":"9596","key":"10.1016\/j.ijsu.2020.07.004_bib10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet Lond. Engl."},{"issue":"5","key":"10.1016\/j.ijsu.2020.07.004_bib11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijsu.2020.07.004_bib12","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","author":"Shea","year":"2017","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.ijsu.2020.07.004_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.ijsu.2020.07.004_bib14","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","article-title":"Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis","volume":"43","author":"Alyami","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2020.07.004_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2020.05.007","article-title":"Standardizing training for pressurized intraperitoneal aerosol chemotherapy","author":"Alyami","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.ijsu.2020.07.004_bib16","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1177\/0300060518778637","article-title":"The scientific report from the first pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures performed in the eastern part of Central Europe","volume":"46","author":"Nowacki","year":"2018","journal-title":"J. Int. Med. Res."},{"issue":"9695","key":"10.1016\/j.ijsu.2020.07.004_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"issue":"Suppl 5","key":"10.1016\/j.ijsu.2020.07.004_bib18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1245\/s10434-016-5108-4","article-title":"In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC)","volume":"23","author":"Kakchekeeva","year":"2016","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.ijsu.2020.07.004_bib19","doi-asserted-by":"crossref","unstructured":"Rovers KP, Lurvink RJ, Wassenaar EC, et al. Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC). BMJ Open;9(7):e030408.","DOI":"10.1136\/bmjopen-2019-030408"},{"issue":"17","key":"10.1016\/j.ijsu.2020.07.004_bib20","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/jama.2015.12020","article-title":"Confluence, not conflict of interest: name change necessary","volume":"314","author":"Cappola","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ijsu.2020.07.004_bib21","series-title":"Of the Council on Guidelines for Managing Conflict of Interest in the Public Service","author":"Recommendation","year":"2003"},{"key":"10.1016\/j.ijsu.2020.07.004_bib22","series-title":"Ordre des M\u00e9decins","year":"2012"},{"key":"10.1016\/j.ijsu.2020.07.004_bib23","series-title":"Principles of Biomedical Ethics","author":"Beauchamp","year":"2008"},{"issue":"2","key":"10.1016\/j.ijsu.2020.07.004_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2013.11.022","article-title":"Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience","volume":"132","author":"Tempfer","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ijsu.2020.07.004_bib25","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.ejso.2015.06.001","article-title":"Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)","volume":"41","author":"Odendahl","year":"2015","journal-title":"Euro. J. Surg. Oncol. EJSO"},{"issue":"12","key":"10.1016\/j.ijsu.2020.07.004_bib26","first-page":"6723","article-title":"Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study","volume":"35","author":"Tempfer","year":"2015","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.ijsu.2020.07.004_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ijsu.2020.07.004_bib28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtr\u00f6der","year":"2016","journal-title":"Colorectal Dis."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12957-016-1008-0","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Girshally","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ijsu.2020.07.004_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis","volume":"20","author":"Nadiradze","year":"2016","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","volume":"14","author":"Robella","year":"2016","journal-title":"World J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.ijsu.2020.07.004_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/pp-2016-0021","article-title":"Single-port access for pressurized IntraPeritoneal aerosol chemotherapy (PIPAC): technique, feasibility and safety","volume":"1","author":"Vaira","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"5","key":"10.1016\/j.ijsu.2020.07.004_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10585-017-9849-7","article-title":"Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"34","author":"Graversen","year":"2017","journal-title":"Clin. Exp. Metastasis"},{"issue":"6","key":"10.1016\/j.ijsu.2020.07.004_bib34","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.3802\/jgo.2017.28.e80","article-title":"Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis","volume":"28","author":"Hilal","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ijsu.2020.07.004_bib35","series-title":"PLOS ONE","article-title":"Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma","volume":"12","author":"Khosrawipour","year":"2017"},{"issue":"3","key":"10.1016\/j.ijsu.2020.07.004_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/pp-2016-0017","article-title":"Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2)","volume":"1","author":"Khomyakov","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.ijsu.2020.07.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6852749","article-title":"Feasibility and safety of pressurized intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis: a retrospective cohort study","volume":"2017","author":"H\u00fcbner","year":"2017","journal-title":"Gastroenterol. Res. Pract."},{"issue":"6","key":"10.1016\/j.ijsu.2020.07.004_bib38","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy \u2013 practical aspects","volume":"43","author":"H\u00fcbner","year":"2017","journal-title":"Euro. J. Surg. Oncol. EJSO"},{"key":"10.1016\/j.ijsu.2020.07.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4596176","article-title":"Impact of pressurized intraperitoneal aerosol chemotherapy on quality of life and symptoms in patients with peritoneal carcinomatosis: a retrospective cohort study","volume":"2017","author":"Teixeira Farinha","year":"2017","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.ijsu.2020.07.004_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918777036","article-title":"Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis","volume":"10","author":"Graversen","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"12","key":"10.1016\/j.ijsu.2020.07.004_bib41","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.21873\/anticanres.13062","article-title":"No renal toxicity after repeated treatment with pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with unresectable peritoneal metastasis","volume":"38","author":"Larbre","year":"2018","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib42","first-page":"373","article-title":"Clinical data of pressurized intraperitoneal aerosol chemotherapy (PIPAC) as salvage therapy for peritoneal metastatic biliary tract cancer","volume":"38","author":"First","year":"2018","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib43","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12885-018-4363-0","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy (PIPAC) for the treatment of malignant mesothelioma","volume":"18","author":"Giger-Pabst","year":"2018","journal-title":"BMC Canc."},{"issue":"4","key":"10.1016\/j.ijsu.2020.07.004_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5230\/jgc.2018.18.e37","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study","volume":"18","author":"Gockel","year":"2018","journal-title":"J. Gastric. Canc."},{"issue":"7","key":"10.1016\/j.ijsu.2020.07.004_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10585-018-9925-7","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer","volume":"35","author":"Horvath","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ijsu.2020.07.004_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2743985","article-title":"Feasibility, safety, and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: a registry study","volume":"2018","author":"Kurtz","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","article-title":"A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis","volume":"150","author":"Tempfer","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ijsu.2020.07.004_bib48","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.ejso.2018.04.020","article-title":"Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis","volume":"44","author":"Tempfer","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.7150\/jca.21460","article-title":"Inflammatory response and toxicity after pressurized IntraPeritoneal aerosol chemotherapy","volume":"9","author":"Teixeira Farinha","year":"2018","journal-title":"J. Canc."},{"issue":"5","key":"10.1016\/j.ijsu.2020.07.004_bib50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jclinpath-2018-205683","article-title":"Detection of free intraperitoneal tumour cells in peritoneal lavage fluid from patients with peritoneal metastasis before and after treatment with pressurised intraperitoneal aerosol chemotherapy (PIPAC)","volume":"72","author":"Graversen","year":"2019","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.ijsu.2020.07.004_bib51","doi-asserted-by":"crossref","first-page":"20180128","DOI":"10.1515\/pp-2018-0128","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy (PIPAC) as an outpatient procedure","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"7","key":"10.1016\/j.ijsu.2020.07.004_bib52","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/his.13829","article-title":"Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis","volume":"74","author":"Solass","year":"2019","journal-title":"Histopathology"},{"issue":"19","key":"10.1016\/j.ijsu.2020.07.004_bib53","first-page":"30349","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative study","volume":"S0748\u20137983","author":"Siebert","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ijsu.2020.07.004_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13193-018-0771-5","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC): initial experience from Indian centers and a review of literature","volume":"10","author":"Katdare","year":"2019","journal-title":"Indian J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.ijsu.2020.07.004_bib55","doi-asserted-by":"crossref","first-page":"20180110","DOI":"10.1515\/pp-2018-0110","article-title":"Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy","volume":"3","author":"Somashekhar","year":"2018","journal-title":"Pleura Peritoneum"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919120305392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919120305392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:04:59Z","timestamp":1677081899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919120305392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":55,"alternative-id":["S1743919120305392"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2020.07.004","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restricted access to innovative surgical technique related to a specific training, is it ethical? Example of the PIPAC procedure. A systematic review and an experts survey","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}